Home
Conditions
Lymphoma, Mantle-Cell

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

894 public trials 110 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Completed

Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

NCT00003039

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
Locations: Clinical Sciences Building Chicago, Illinois, United States

University of Chicago Cancer Research Center Chicago, Illinois, United States

Louis A. Weiss Memorial Hospital Chicago, Illinois, United States

Cancer Care Specialists of Central Illinois, S.C. Decatur, Illinois, United States

View Trial Details

Completed

Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00002725

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma

NCT00002759

Conditions: Agranulocytosis, Burkitt Lymphoma, Chemically-Induced Disorders, +51 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

View Trial Details

Completed

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

NCT00003451

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma

NCT00016094

Conditions: Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +22 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas

NCT00089271

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +97 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas

NCT00098891

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +92 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma

NCT00003970

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, +99 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00077155

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, +95 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

NCT00086944

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Lymphoma, Mantle-Cell

Lymphoma, Mantle-Cell trial results

Related conditions